by Yves Adele Harlow » 25 Nov 2022 08:00
Several years ago, the Food and Drug Administration (FDA) decided that access to veterinary antibiotics was too easy for the average citizen. They announced that there would be an increased “stewardship” of these drugs (life-savers in survival settings) in the future. Thus began the implementation of Industry Guidance #213, also known as the Veterinary Feed Directive (VFD). This action was meant to discourage the use of veterinary antibiotics and, hopefully, decrease antibiotic resistance.
While this directive applied to food-producing livestock, there was no rule against access to antibiotics used in the pet trade, specifically those targeting aquarium fish or pet birds. Despite this, the writing was on the wall; large distributors like Thomas Labs, maker of “Fish-Mox,” quietly ended their line of products. Other producers rose to fill the void, but the selection was less and availability less reliable.
Recently, the FDA issued Industry
Guidance #263, a ruling that all remaining over-the-counter “medically-important” veterinary antibiotics should be “transitioned” to prescription-only by
June 2023. Product labels will now state: “Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.”
READ FULL ARTICLE HERE
Several years ago, the Food and Drug Administration (FDA) decided that access to veterinary antibiotics was too easy for the average citizen. They announced that there would be an increased “stewardship” of these drugs (life-savers in survival settings) in the future. Thus began the implementation of Industry Guidance #213, also known as the Veterinary Feed Directive (VFD). This action was meant to discourage the use of veterinary antibiotics and, hopefully, decrease antibiotic resistance.
While this directive applied to food-producing livestock, there was no rule against access to antibiotics used in the pet trade, specifically those targeting aquarium fish or pet birds. Despite this, the writing was on the wall; large distributors like Thomas Labs, maker of “Fish-Mox,” quietly ended their line of products. Other producers rose to fill the void, but the selection was less and availability less reliable.
Recently, the FDA issued Industry [url=https://www.drovers.com/news/industry/new-antibiotic-restrictions-soon-become-reality]Guidance #263[/url], a ruling that all remaining over-the-counter “medically-important” veterinary antibiotics should be “transitioned” to prescription-only by [url=https://www.pbsanimalhealth.com/pages/antibiotics-moving-to-rx-in-2023]June 2023[/url]. Product labels will now state: “Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.” [url=https://www.doomandbloom.net/the-fda-and-veterinary-antibiotics/]➡️ READ FULL ARTICLE HERE[/url]
[img]https://www.doomandbloom.net/wp-content/uploads/2012/03/shutterstock_1784978723-2048x1441.jpg[/img]
